Short, N. J., Macaron, W., Kadia, T., Dinardo, C., Issa, G. C., Daver, N., Wang, S., Jorgensen, J., Nguyen, D., Bidikian, A., Patel, K. P., Loghavi, S., Konopleva, M., Yilmaz, M., Jabbour, E., Maiti, A., Abbas, H. A., Shpall, E., Popat, U., Al‐Atrash, G., Pierce, S., Kantarjian, H. M., & Ravandi, F. (2022). clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission. American journal of hematology, 97(11), E408–E411. http://access.bl.uk/ark:/81055/vdc_100167907018.0x00004d